Patents by Inventor Soltani NEPTON

Soltani NEPTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of ameliorating symptoms of type 1-diabetes using GABA related compounds and GLP-1/exendin-4 compounds
    Patent number: 8680051
    Abstract: A composition for the prevention or treatment of type I diabetes in a subject, said composition comprising a GABAergic and incretin exemplified by GABA and GLP-1/Ex4. These are optionally provided together in a single composition to promote beta-cell regeneration prevent beta-cell apoptosis and control autoimmunity for the prevention and treatment of T1D in mammals.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: March 25, 2014
    Inventors: Qinghua Wang, Soltani Nepton
  • Pharmaceutical Composition for the Treatment of Type 1-Diabetes
    Publication number: 20100166675
    Abstract: A composition for the prevention or treatment of type I diabetes in a subject, said composition comprising a GABAergic and incretin exemplified by GABA and GLP-1/Ex4. These are optionally provided together in a single composition to promote beta-cell regeneration prevent beta-cell apoptosis and control autoimmunity for the prevention and treatment of T1D in mammals.
    Type: Application
    Filed: December 21, 2009
    Publication date: July 1, 2010
    Inventors: Qinghua WANG, Soltani NEPTON